Kiniksa Pharmaceuticals International, plc (KNSA) › Total AssetsKiniksa Pharmaceuticals International, plc (KNSA) — Total AssetsAnnual figures by period end, from SEC filings.2017-12-31: $47.49M2018-12-31: $321.96M2019-12-31: $254.53M2020-12-31: $349.46M2021-12-31: $232.80M2022-12-31: $459.67M2023-12-31: $526.32M2024-12-31: $580.55M2025-12-31: $763.63M$763.63M2017-12-31Total Assets (USD)2025-12-31Period endedTotal AssetsChange YoYSource filing2025-12-31$763.63M+31.5%2026-02-24Balance as of period end2024-12-31$580.55M+10.3%2026-02-24Balance as of period end2023-12-31$526.32M+14.5%2025-02-25Balance as of period end2022-12-31$459.67M+97.5%2024-02-28Balance as of period end2021-12-31$232.80M-33.4%2023-03-02Balance as of period end2020-12-31$349.46M+37.3%2022-02-24Balance as of period end2019-12-31$254.53M-20.9%2021-02-25Balance as of period end2018-12-31$321.96M+577.9%2020-03-05Balance as of period end2017-12-31$47.49M—2019-03-12Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)